SEARCH RESULTS FOR: "Tag: SGMO"
REFINE YOUR SEARCH:
RECENT
Last Month(1)
ARTICLES/BLOGS
2019(1)
2018(4)
2017(5)
2015(1)
CATEGORIES
Analyst Update(3)
Analyst Upgrades(1)
Quantitative Analysis(1)
Stocks On the Move(7)
Technical Analysis(1)

2/7/2019 2:58 PM
Stocks are staring at stiff losses following fresh U.S.-China trade news. Among individual names making big moves lower are ePort parent USA Technologies, Inc. (NASDAQ:USAT), biotech Sangamo Therap...
9/5/2018 2:53 PM
It's a mixed trading day on Wall Street, with the tech sector lagging on regulatory concerns. Among individual stocks making volatile moves are genome editing firm Sangamo Therapeutics Inc (NASDAQ:S...
4/19/2018 1:15 PM
Biotech stock Sangamo Therapeutics Inc (NASDAQ:SGMO) touched a 17-year high of $27.50 on Feb. 22, after the company announced a $3 billion gene-editing deal with Gilead Sciences (GILD). Since then,...
2/22/2018 12:59 PM
U.S. stocks have steadily climbed today, as interest-rate hike concerns begin to die down. Dow component United Technologies Corporation (NYSE:UTX) and biotech stock Sangamo Therapeutics Inc (NASDAQ:S...
1/3/2018 2:24 PM
As the U.S. stock market carves out record highs, several individual equities are making big moves on high-profile collaborative partnerships. Two such names are former smartphone maker BlackBerry L...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center